The Melody Transcatheter Pulmonary Valve: 10-Year Outcomes in the Original US Investigational Device Exemption Trial Cohort
Thomas K. Jones, M.D., MSCAI, Seattle Children’s Hospital, Seattle, WA, Doff B. Mcelhinney, M.D., FSCAI, Lucile Packard Children's Hospital at Stanford, Los Altos, CA, Julie A. Vincent, M.D., FSCAI, Columbia University Medical Center, New York, NY, William E. Hellenbrand, M.D., Yale University, New Haven, CT, John P. Cheatham, M.D., MSCAI, Nationwide Children's Hospital, Plymouth, MA, Darren P. Berman, M.D., FSCAI, Nationwide Children's Hospital, Columbus, OH, Evan M. Zahn, MD, MSCAI, Cedars-Sinai Medical Center, Los Angeles, CA, Danyal M. Khan, M.D., Miami Children's Hospital, Miami, FL, John F. Rhodes Jr., M.D., Medical University of South Carolina, Charleston, SC, Shicheng Weng, MS, -, Mounds View, MN and Lisa Bergersen, M.D., MPH, FSCAI, Children's Hospital Boston, Boston, MA